Lipopolysaccharides Enhance Epithelial Hyperplasia and Tubular Adenoma in Intestine-Specific Expression of <i>kras<sup>V</sup></i><sup>12</sup> in Transgenic Zebrafish

Intestinal carcinogenesis is a multistep process that begins with epithelial hyperplasia, followed by a transition to an adenoma and then to a carcinoma. Many etiological factors, including <i>KRAS</i> mutations and inflammation, have been implicated in oncogenesis. However, the potentia...

Full description

Bibliographic Details
Main Authors: Jeng-Wei Lu, Yuxi Sun, Pei-Shi Angelina Fong, Liang-In Lin, Dong Liu, Zhiyuan Gong
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/9/8/974
_version_ 1797524586935353344
author Jeng-Wei Lu
Yuxi Sun
Pei-Shi Angelina Fong
Liang-In Lin
Dong Liu
Zhiyuan Gong
author_facet Jeng-Wei Lu
Yuxi Sun
Pei-Shi Angelina Fong
Liang-In Lin
Dong Liu
Zhiyuan Gong
author_sort Jeng-Wei Lu
collection DOAJ
description Intestinal carcinogenesis is a multistep process that begins with epithelial hyperplasia, followed by a transition to an adenoma and then to a carcinoma. Many etiological factors, including <i>KRAS</i> mutations and inflammation, have been implicated in oncogenesis. However, the potential synergistic effects between <i>KRAS</i> mutations and inflammation as well as the potential mechanisms by which they promote intestinal carcinogenesis remain unclear. Thus, the objective of this study was to investigate the synergistic effects of <i>kras<sup>V</sup></i><sup>12</sup>, lipopolysaccharides (LPS), and/or dextran sulfate sodium (DSS) on inflammation, tumor progression, and intestinal disorders using transgenic adults and larvae of zebrafish. Histopathology and pathological staining were used to examine the intestines of <i>kras<sup>V</sup></i><sup>12</sup> transgenic zebrafish treated with LPS and/or DSS. LPS and/or DSS treatment enhanced intestinal inflammation in <i>kras<sup>V</sup></i><sup>12</sup> transgenic larvae with concomitant increases in the number of neutrophils and macrophages in the intestines. The expression of <i>kras<sup>V</sup></i><sup>12</sup>, combined with LPS treatment, also enhanced epithelial hyperplasia and tubular adenoma, demonstrated by histopathological examinations and by increases in cell apoptosis, cell proliferation, and downstream signaling of phosphorylated AKT serine/threonine kinase 1 (AKT), extracellular-signal-regulated kinase (ERK), and histone. We also found that <i>kras<sup>V</sup></i><sup>12</sup> expression, combined with LPS treatment, significantly enhanced changes in intestinal morphology, specifically (1) decreases in goblet cell number, goblet cell size, villi height, and intervilli space, as well as (2) increases in villi width and smooth muscle thickness. Moreover, <i>kras<sup>V</sup></i><sup>12</sup> transgenic larvae cotreated with DSS and LPS exhibited exacerbated intestinal inflammation. Cotreatment with DSS and LPS in <i>kras<sup>V</sup></i><sup>12</sup>-expressing transgenic adult zebrafish also enhanced epithelial hyperplasia and tubular adenoma, compared with wild-type fish that received the same cotreatment. In conclusion, our data suggest that <i>kras<sup>V</sup></i><sup>12</sup> expression, combined with LPS and/or DSS treatment, can enhance intestinal tumor progression by activating the phosphatidylinositol-3-kinase (PI3K)/AKT signaling pathway and may provide a valuable in vivo platform to investigate tumor initiation and antitumor drugs for gastrointestinal cancers.
first_indexed 2024-03-10T08:59:34Z
format Article
id doaj.art-88e411ba8b734eca8d39e11ef544c015
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T08:59:34Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-88e411ba8b734eca8d39e11ef544c0152023-11-22T06:52:48ZengMDPI AGBiomedicines2227-90592021-08-019897410.3390/biomedicines9080974Lipopolysaccharides Enhance Epithelial Hyperplasia and Tubular Adenoma in Intestine-Specific Expression of <i>kras<sup>V</sup></i><sup>12</sup> in Transgenic ZebrafishJeng-Wei Lu0Yuxi Sun1Pei-Shi Angelina Fong2Liang-In Lin3Dong Liu4Zhiyuan Gong5Department of Biological Sciences, National University of Singapore, Singapore 117543, SingaporeDepartment of Biological Sciences, National University of Singapore, Singapore 117543, SingaporeDepartment of Biological Sciences, National University of Singapore, Singapore 117543, SingaporeDepartment of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei 10048, TaiwanDepartment of Biology, Southern University of Science and Technology, Shenzhen 518055, ChinaDepartment of Biological Sciences, National University of Singapore, Singapore 117543, SingaporeIntestinal carcinogenesis is a multistep process that begins with epithelial hyperplasia, followed by a transition to an adenoma and then to a carcinoma. Many etiological factors, including <i>KRAS</i> mutations and inflammation, have been implicated in oncogenesis. However, the potential synergistic effects between <i>KRAS</i> mutations and inflammation as well as the potential mechanisms by which they promote intestinal carcinogenesis remain unclear. Thus, the objective of this study was to investigate the synergistic effects of <i>kras<sup>V</sup></i><sup>12</sup>, lipopolysaccharides (LPS), and/or dextran sulfate sodium (DSS) on inflammation, tumor progression, and intestinal disorders using transgenic adults and larvae of zebrafish. Histopathology and pathological staining were used to examine the intestines of <i>kras<sup>V</sup></i><sup>12</sup> transgenic zebrafish treated with LPS and/or DSS. LPS and/or DSS treatment enhanced intestinal inflammation in <i>kras<sup>V</sup></i><sup>12</sup> transgenic larvae with concomitant increases in the number of neutrophils and macrophages in the intestines. The expression of <i>kras<sup>V</sup></i><sup>12</sup>, combined with LPS treatment, also enhanced epithelial hyperplasia and tubular adenoma, demonstrated by histopathological examinations and by increases in cell apoptosis, cell proliferation, and downstream signaling of phosphorylated AKT serine/threonine kinase 1 (AKT), extracellular-signal-regulated kinase (ERK), and histone. We also found that <i>kras<sup>V</sup></i><sup>12</sup> expression, combined with LPS treatment, significantly enhanced changes in intestinal morphology, specifically (1) decreases in goblet cell number, goblet cell size, villi height, and intervilli space, as well as (2) increases in villi width and smooth muscle thickness. Moreover, <i>kras<sup>V</sup></i><sup>12</sup> transgenic larvae cotreated with DSS and LPS exhibited exacerbated intestinal inflammation. Cotreatment with DSS and LPS in <i>kras<sup>V</sup></i><sup>12</sup>-expressing transgenic adult zebrafish also enhanced epithelial hyperplasia and tubular adenoma, compared with wild-type fish that received the same cotreatment. In conclusion, our data suggest that <i>kras<sup>V</sup></i><sup>12</sup> expression, combined with LPS and/or DSS treatment, can enhance intestinal tumor progression by activating the phosphatidylinositol-3-kinase (PI3K)/AKT signaling pathway and may provide a valuable in vivo platform to investigate tumor initiation and antitumor drugs for gastrointestinal cancers.https://www.mdpi.com/2227-9059/9/8/974colorectal cancerdextran sulfate sodiumlipopolysaccharides<i>kras<sup>V</sup></i><sup>12</sup>intestinal tumortransgenic zebrafish
spellingShingle Jeng-Wei Lu
Yuxi Sun
Pei-Shi Angelina Fong
Liang-In Lin
Dong Liu
Zhiyuan Gong
Lipopolysaccharides Enhance Epithelial Hyperplasia and Tubular Adenoma in Intestine-Specific Expression of <i>kras<sup>V</sup></i><sup>12</sup> in Transgenic Zebrafish
Biomedicines
colorectal cancer
dextran sulfate sodium
lipopolysaccharides
<i>kras<sup>V</sup></i><sup>12</sup>
intestinal tumor
transgenic zebrafish
title Lipopolysaccharides Enhance Epithelial Hyperplasia and Tubular Adenoma in Intestine-Specific Expression of <i>kras<sup>V</sup></i><sup>12</sup> in Transgenic Zebrafish
title_full Lipopolysaccharides Enhance Epithelial Hyperplasia and Tubular Adenoma in Intestine-Specific Expression of <i>kras<sup>V</sup></i><sup>12</sup> in Transgenic Zebrafish
title_fullStr Lipopolysaccharides Enhance Epithelial Hyperplasia and Tubular Adenoma in Intestine-Specific Expression of <i>kras<sup>V</sup></i><sup>12</sup> in Transgenic Zebrafish
title_full_unstemmed Lipopolysaccharides Enhance Epithelial Hyperplasia and Tubular Adenoma in Intestine-Specific Expression of <i>kras<sup>V</sup></i><sup>12</sup> in Transgenic Zebrafish
title_short Lipopolysaccharides Enhance Epithelial Hyperplasia and Tubular Adenoma in Intestine-Specific Expression of <i>kras<sup>V</sup></i><sup>12</sup> in Transgenic Zebrafish
title_sort lipopolysaccharides enhance epithelial hyperplasia and tubular adenoma in intestine specific expression of i kras sup v sup i sup 12 sup in transgenic zebrafish
topic colorectal cancer
dextran sulfate sodium
lipopolysaccharides
<i>kras<sup>V</sup></i><sup>12</sup>
intestinal tumor
transgenic zebrafish
url https://www.mdpi.com/2227-9059/9/8/974
work_keys_str_mv AT jengweilu lipopolysaccharidesenhanceepithelialhyperplasiaandtubularadenomainintestinespecificexpressionofikrassupvsupisup12supintransgeniczebrafish
AT yuxisun lipopolysaccharidesenhanceepithelialhyperplasiaandtubularadenomainintestinespecificexpressionofikrassupvsupisup12supintransgeniczebrafish
AT peishiangelinafong lipopolysaccharidesenhanceepithelialhyperplasiaandtubularadenomainintestinespecificexpressionofikrassupvsupisup12supintransgeniczebrafish
AT lianginlin lipopolysaccharidesenhanceepithelialhyperplasiaandtubularadenomainintestinespecificexpressionofikrassupvsupisup12supintransgeniczebrafish
AT dongliu lipopolysaccharidesenhanceepithelialhyperplasiaandtubularadenomainintestinespecificexpressionofikrassupvsupisup12supintransgeniczebrafish
AT zhiyuangong lipopolysaccharidesenhanceepithelialhyperplasiaandtubularadenomainintestinespecificexpressionofikrassupvsupisup12supintransgeniczebrafish